NCT04150887Active, not recruitingPhase 1
An Open-label, Multicenter, Phase 1b Study of OV-1001 (Cusatuzumab; Anti-CD70 Monoclonal Antibody) in Combination with Background Therapy for the Treatment of Subjects with Acute Myeloid Leukemia
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Oct 2026
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 5 Jul 2024
- Start date
- 1 Jul 2020
- Lead sponsor
- OncoVerity Inc.
- Diseases
- Acute myeloid leukemia
- EU CT number
- 2024-513276-17-00
- EudraCT number
- 2019-002808-41
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 10
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Leipzig Aor Coordinator of this site? Confirm its status | Leipzig | Germany | Active, not recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.